Apixaban following discharge in hospitalised adults with COVID-19: Preliminary results from a multicentre, open-label, randomised controlled platform clinical trial
View ORCID ProfileMark R Toshner, View ORCID ProfileCarrol Gamble, View ORCID ProfileJ Kenneth Baillie, Ashley Best, Emma Bedson, Judy Bradley, Melanie Calvert, Elin Haf Davies, View ORCID ProfileAnnemarie B Docherty, Efstathia Gkioni, Dyfrig A Hughes, Thomas Jaki, R Gisli Jenkins, Ashley Jones, Martin J Landray, Jonathan Mant, Daniel F McAuley, View ORCID ProfilePeter JM Openshaw, Duncan Richards, Paul Wicks, HEAL-COVID Collaboration, View ORCID ProfileCharlotte Summers
doi: https://doi.org/10.1101/2022.12.07.22283175
Mark R Toshner
1University of Cambridge
Carrol Gamble
2University of Liverpool
J Kenneth Baillie
3Roslin Institute, University of Edinburgh
Ashley Best
2University of Liverpool
Emma Bedson
2University of Liverpool
Judy Bradley
4Queen’s University, Belfast
Melanie Calvert
5University of Birmingham
Elin Haf Davies
6Aparito Limited
Annemarie B Docherty
7University of Edinburgh
Efstathia Gkioni
2University of Liverpool
Dyfrig A Hughes
8Bangor University
Thomas Jaki
9MRC Biostatistics Unit, University of Cambridge
R Gisli Jenkins
10Imperial College London
Ashley Jones
2University of Liverpool
Martin J Landray
11University of Oxford
Jonathan Mant
1University of Cambridge
Daniel F McAuley
12Queen’s University Belfast
Peter JM Openshaw
10Imperial College London
Duncan Richards
11University of Oxford
Paul Wicks
13Wicks Digital Health
Charlotte Summers
1University of Cambridge
Data Availability
Deidentified patient data will be available after the primary results have been published. Requests will be reviewed by the Trial Management Group and where at all possible access will be granted.
Posted December 07, 2022.
Apixaban following discharge in hospitalised adults with COVID-19: Preliminary results from a multicentre, open-label, randomised controlled platform clinical trial
Mark R Toshner, Carrol Gamble, J Kenneth Baillie, Ashley Best, Emma Bedson, Judy Bradley, Melanie Calvert, Elin Haf Davies, Annemarie B Docherty, Efstathia Gkioni, Dyfrig A Hughes, Thomas Jaki, R Gisli Jenkins, Ashley Jones, Martin J Landray, Jonathan Mant, Daniel F McAuley, Peter JM Openshaw, Duncan Richards, Paul Wicks, HEAL-COVID Collaboration, Charlotte Summers
medRxiv 2022.12.07.22283175; doi: https://doi.org/10.1101/2022.12.07.22283175
Apixaban following discharge in hospitalised adults with COVID-19: Preliminary results from a multicentre, open-label, randomised controlled platform clinical trial
Mark R Toshner, Carrol Gamble, J Kenneth Baillie, Ashley Best, Emma Bedson, Judy Bradley, Melanie Calvert, Elin Haf Davies, Annemarie B Docherty, Efstathia Gkioni, Dyfrig A Hughes, Thomas Jaki, R Gisli Jenkins, Ashley Jones, Martin J Landray, Jonathan Mant, Daniel F McAuley, Peter JM Openshaw, Duncan Richards, Paul Wicks, HEAL-COVID Collaboration, Charlotte Summers
medRxiv 2022.12.07.22283175; doi: https://doi.org/10.1101/2022.12.07.22283175
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2913)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12701)
- Forensic Medicine (12)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4557)
- Geriatric Medicine (414)
- Health Economics (724)
- Health Informatics (2909)
- Health Policy (1068)
- Hematology (385)
- HIV/AIDS (921)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4324)
- Nursing (234)
- Nutrition (634)
- Oncology (2256)
- Ophthalmology (642)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6910)
- Radiology and Imaging (1522)
- Respiratory Medicine (914)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (484)
- Toxicology (60)
- Transplantation (209)
- Urology (178)